Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal Function.

Postorino MC, Quiros-Roldan E, Maggiolo F, Di Giambenedetto S, Ladisa N, Lapadula G, Lorenzotti S, Sighinolfi L, Castelnuovo F, Di Pietro M, Gotti D, Mazzini N, Torti C; MASTER Study Group.

Open AIDS J. 2016 Jul 15;10:136-43. doi: 10.2174/1874613601610010136. eCollection 2016.

2.

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Lucas GM, Ross MJ, Stock PG, Shlipak MG, Wyatt CM, Gupta SK, Atta MG, Wools-Kaloustian KK, Pham PA, Bruggeman LA, Lennox JL, Ray PE, Kalayjian RC; HIV Medicine Association of the Infectious Diseases Society of America.

Clin Infect Dis. 2014 Nov 1;59(9):e96-138. doi: 10.1093/cid/ciu617. Epub 2014 Sep 17.

3.

Impact of antiretroviral therapy on renal function among HIV-infected Tanzanian adults: a retrospective cohort study.

Mpondo BC, Kalluvya SE, Peck RN, Kabangila R, Kidenya BR, Ephraim L, Fitzgerald DW, Downs JA.

PLoS One. 2014 Feb 26;9(2):e89573. doi: 10.1371/journal.pone.0089573. eCollection 2014.

4.

Late presentation to HIV/AIDS testing, treatment or continued care: clarifying the use of CD4 evaluation in the consensus definition.

MacCarthy S, Bangsberg DR, Fink G, Reich M, Gruskin S.

HIV Med. 2014 Mar;15(3):130-4. doi: 10.1111/hiv.12088. Epub 2013 Sep 11.

5.

Kidney disease in children and adolescents with perinatal HIV-1 infection.

Bhimma R, Purswani MU, Kala U.

J Int AIDS Soc. 2013 Jun 18;16:18596. doi: 10.7448/IAS.16.1.18596. Review.

6.

Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy.

Foy MC, Estrella MM, Lucas GM, Tahir F, Fine DM, Moore RD, Atta MG.

Clin J Am Soc Nephrol. 2013 Sep;8(9):1524-32. doi: 10.2215/CJN.10991012. Epub 2013 May 16.

7.

Chronic kidney disease associated with perinatal HIV infection in children and adolescents.

Purswani MU, Chernoff MC, Mitchell CD, Seage GR 3rd, Zilleruelo G, Abitbol C, Andiman WA, Kaiser KA, Spiegel H, Oleske JM; IMPAACT 219/219C Study Team.

Pediatr Nephrol. 2012 Jun;27(6):981-9. doi: 10.1007/s00467-011-2097-1. Epub 2012 Feb 26.

8.

Recent developments in HIV-related kidney disease.

Estrella MM, Fine DM, Atta MG.

HIV Ther. 2010 Sep;4(5):589-603.

9.

The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.

Estrella MM, Parekh RS, Abraham A, Astor BC, Szczech LA, Anastos K, Dehovitz JA, Merenstein DJ, Pearce CL, Tien PC, Cohen MH, Gange SJ.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):217-20. doi: 10.1097/QAI.0b013e3181e674f4.

10.

Screening for chronic kidney disease in HIV-infected patients.

Estrella MM, Fine DM.

Adv Chronic Kidney Dis. 2010 Jan;17(1):26-35. doi: 10.1053/j.ackd.2009.07.014. Review.

11.

HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy.

Choi AI, Shlipak MG, Hunt PW, Martin JN, Deeks SG.

AIDS. 2009 Oct 23;23(16):2143-9. doi: 10.1097/QAD.0b013e3283313c91.

12.

Incidence of persistent renal dysfunction in human immunodeficiency virus-infected children: associations with the use of antiretrovirals, and other nephrotoxic medications and risk factors.

Andiman WA, Chernoff MC, Mitchell C, Purswani M, Oleske J, Williams PL, Spiegel H, Gona P, Seage GR 3rd; PACTG iDACS 617 Study Team.

Pediatr Infect Dis J. 2009 Jul;28(7):619-25. doi: 10.1097/INF.0b013e31819ca49a.

13.

Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races.

Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD.

J Infect Dis. 2008 Jun 1;197(11):1548-57. doi: 10.1086/587994.

14.

Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland.

Atta MG, Fine DM, Kirk GD, Mehta SH, Moore RD, Lucas GM.

Clin Infect Dis. 2007 Dec 15;45(12):1625-32. doi: 10.1086/523728. Erratum in: Clin Infect Dis. 2008 Feb 1;46(3):488.

Supplemental Content

Support Center